ReviewCancer journal (Sudbury, Mass.)

T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies.

Melinda A Biernacki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.